Drug Shortage Report for PRALUENT

Last updated on 2019-04-18 History
Report ID 80305
Drug Identification Number 02453819
Brand name PRALUENT
Common or Proper name Praluent Pen 75mg/mL
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) ALIROCUMAB
Strength(s) 75MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2 pre-filled pens
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-04-15
Actual start date
Estimated end date 2019-05-06
Actual end date 2019-04-17
Shortage status Resolved
Updated date 2019-04-18
Company comments TEMPORARY SHORTAGE OF PRALUENT, 75mg/mL & 150mg/mL (Alirocumab) We recognize the difficulties that this situation may cause for patients and health care providers. We apologize for any inconvenience resulting from this. Please note that both strengths (75 mg/mL and 150mg/mL) are not equivalent. For more information, please contact your healthcare professional. All efforts are being made to resolve the situation and any update will be communicated on the www.drugshortagescanada.ca website.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-04-18 French Compare
v4 2019-04-18 English Compare
v3 2019-04-16 English Compare
v2 2019-04-02 French Compare
v1 2019-04-02 English Compare